Clinical trial · Observational
Mobilization of Mesenchymal Stem Cells During Liver Transplantation
NCT02557724CI-TRIAL-00035291completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To study if the administration of corticoid hinder or enhance the mobilization of Mesenchymal Stem Cells (MSCs) in the peripheral blood during liver transplantation and whether this affects the outcome with respect to graft versus host response.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Failure | — | UNRESOLVED | — |
| Liver Neoplasm | Liver Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood samples | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- liver transplant patients
- description
- 5 blood samples at time points as described in protocol
- interventionNames
- Procedure: blood samples
- label
- Liver resection patients
- description
- 3 blood samples at time points described in protocol
- interventionNames
- Procedure: blood samples
Primary outcomes (1)
- measure
- post operative liver injury
- timeFrame
- 0-7 post operative days
- description
- . Primary endpoint is defined by postoperative liver injury assessed by peak serum value of aspartate aminotransferase (AST) or alanine aminotransferase (ALT).
Secondary outcomes (4)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * • Patients 21-80 capable of providing informed consent * ASA rating between 1-4 * Patients undergoing liver transplant or liver surgery for the first time. Exclusion Criteria: * • Patient less than 21 years of age * Patients unwilling to consent * If donor liver was obtained after cardiac death
References
Publications (0)
Data not yet available
No reference posted for this study.